One Step RSV Rapid Diagnostic Test , Whole Blood/Serum/Plasma Specimen ,Certified, ,quick and easily
 One Step RSV Rapid Diagnostic Test , Whole Blood/Serum/Plasma Specimen ,Certified, ,quick and easily
 One Step RSV Rapid Diagnostic Test , Whole Blood/Serum/Plasma Specimen ,Certified, ,quick and easily

 One Step RSV Rapid Diagnostic Test , Whole Blood/Serum/Plasma Specimen ,Certified, ,quick and easily

MOQ:5000pcs
PRODUCT DESCRIPTION
High Light:

bacterial infection blood test

,

home blood test kit

Brand Name New Life
Certification ISO13485,
Delivery Time 20-30days
Minimum Order Quantity 5000pcs
View More
ABOUT US
Orient New Life Medical Co.,Ltd.
Orient New Life Medical Co.,Ltd. manufacturer profile
12F,Guting Building,Hefeng Creative Square,No.495 Jiangdong North Road,Ningbo,Zhejiang, China ,China
5.0
Verified Supplier
View More
Get the Best Price for
 One Step RSV Rapid Diagnostic Test , Whole Blood/Serum/Plasma Specimen ,Certified, ,quick and easily
 One Step RSV Rapid Diagnostic Test , Whole Blood/Serum/Plasma Specimen ,Certified, ,quick and easily
MOQ: 5000pcs
Continue
Recommended Products
About Us
Orient New Life Medical Co.,Ltd.
Orient New Life Medical Co.,Ltd. manufacturer profile
12F,Guting Building,Hefeng Creative Square,No.495 Jiangdong North Road,Ningbo,Zhejiang, China ,China
5.0
Verified Supplier
Company Name Orient New Life Medical Co.,Ltd.
Business Type: Manufacturer,Exporter
Brands: New Life
No. of Employees: 200~300
Year Established: 2009
Annual Sales: 10,000,000-15,000,000
Company Location 12F,Guting Building,Hefeng Creative Square,No.495 Jiangdong North Road,Ningbo,Zhejiang, China
Factory Location No.1369, Chengnan Road, Jiaxing, Zhejiang, China
China Orient New Life Medical Co.,Ltd. manufacturer profile
China Orient New Life Medical Co.,Ltd. manufacturer profile
China Orient New Life Medical Co.,Ltd. manufacturer profile

Established in 2009, Orient New Life Medical Co., Ltd., is specialized in high-tech biological diagnostic test development, research and production, as well as high-tech medical device development, research and production. New Life has built up two production base, which produce biological diagnostic test and endoscopic medical device respectively. Our products ranged in the following specialties: drug of abuse tests, fertility tests, infectious diseases tests, sexual transmitted diseases tests, tumor markers tests, cardiac markers tests, veterinary tests, and surgical stapler series.

 

NEW LIFE have 3 wholly-owned and joint stock subsidiary companies, including Orient New Life Medical  Co., Ltd., Orient Gene Biotech Co., Ltd., Qianjing Medical Equipment Co., Ltd.

 

Company's core technical team with more than 35 employees,3 doctors and 25 masters. They have many years of famous universities in the United States and pharmaceutical companies engaged in the project research and development, production and marketing, business management experience.Company owns hundreds of grade purification workshop and all level of quality checkout room, equipped with various production and testing equipment.

Get Latest Price For Your Requirement
PRODUCT DESCRIPTION
High Light:

bacterial infection blood test

,

home blood test kit

Place of Origin China
Brand Name New Life
Certification ISO13485,
Model Number Cassette
Minimum Order Quantity 5000pcs
Packaging Details 1pc/pouch, 25pcs/box
Delivery Time 20-30days
Payment Terms T/T, Western Union, MoneyGram
Supply Ability 2000000pcs/month
Classification Infectious
Format Strip/cassette
Specimen Whole Blood/Serum/Plasma
Testing time 5-15 minutes
Shelf Life 24 Months
Application RSV
Accuracy 95.78%

 

 One Step RSV Rapid Diagnostic Test , Whole Blood/Serum/Plasma Specimen ,Certified, ,quick and easily

Description:

One Step RSV Rapid Diagnostic Test , Whole Blood/Serum/Plasma Specimen ,Certified, ,quick and easily

 

Product Name: One Step RSV Rapid Diagnostic Test Cassette

 

 

Intended Use:

 

The Rapid Test of Respiratory Syncytial Virus (RSV) is a chromatographic immunoassay with an instrumented read for the direct and qualitative detection of RSV fusion protein from nasopharyngeal washes/aspirates and nasopharyngeal swabs in transport media from patients suspected of having a viral respiratory infection. This test is intended for in vitro diagnostic use to aid in the diagnosis of RSV infections in infants and pediatric patients under the age of 20 years. Negative results do not preclude RSV infection and should not be used as the sole basis for treatment or for other management decisions. A negative test is presumptive. It is recommended that negative test results be confirmed by viral cell culture or an alternative method, such as a molecular assay. The test is intended for professional and laboratory use.

 

 

TEST PRINCIPLE

 

The RSV Ratest is a chromatographic assay to qualitatively detect RSV viral fusion protein in respiratory specimens. The patient specimen is mixed in a prefilled unitized tube containing RV Reagent C and added to the test device. RV Reagent C contains mucolytic agents that function to break down mucus in a patient specimen thereby exposing viral antigens and enhancing detection in the assay device. Processed specimens are expressed through a filter tip into a single sample well on the RSV test device.

The specimen is mixed and added to the test device where RSV antigens bind to antirespiratory syncytial antibodies conjugated to detector particles on the RSV test strip. The antigen-conjugate complex migrates across the test strip to the reaction area and is captured by an antibody line on the membrane. The assay utilizes a proprietary enhanced colloidal-gold particle at the test lines as the means for identifying the presence of RSV viral antigens.

 

The RSV test devices are designed with four spatially-distinct zones including positive and negative control line positions, test line for the target analyte, and a background zone. The test line for the target analyte is labeled on the test device as ‘T’ for test position. The onboard positive control ensures the sample has flowed correctly and is indicated on the test device as ‘C’. Two of the four distinct zones on the test device are not labeled. These two zones are an onboard negative control line and an assay background zone. The onboard negative control zone addresses non-specific signal generation and is not labeled on the test device. The remaining zone is used to measure the assay background and is also not labeled.

 

TEST PROCEDURE

 

Step 1: Bring the specimen and test components to room temperature if refrigerated or frozen. Once thawed, mix the specimen well prior to performing the assay.

 

Step 2: When ready to test, open the pouch at the notch and remove device. Place the test device on a clean, flat surface.

 

Step 3: Label the device with the specimen ID number.

 

Step 4: Using a squeezing motion, fill the capillary pipette with the serum, plasma or whole blood. Do not exceed the specimen line (see following image). The volume of the specimen is approximately 5 µL. For maximum precision, transfer the specimen using a pipette capable of delivering 5 µL volumes.

 

Holding the capillary pipette vertically, dispense the entire specimen into the center of the sample well (S well), making sure that there are no air bubbles.

 

Immediately add 2 drops (approximately 60-80 µL) of sample diluent into the buffer well (B well) with the bottle positioned vertically

 

INTERPRETATION OF RESULTS

 

Positive:

Two red lines are visible in the result window. The intensity of the test line may be

weaker or darker than that of the control line. This still means a positive result.

 

Negative:

The control line appears in the result window, but the test line is not visible.

 

Invalid:

If the control line does not appear in the result window, the test results are INVALID regardless of the presence or absence of the line in the test region.

 

 

PERFORMANCE CHARACTERS:

 

          Clinical Kit        
    Operator 1       Operator 2    
Sample Positive/total % of   Lower Upper Positive/total % of   Lower Upper
  tested positivity   bound bound tested positivity   bound bound
  swabs   swabs  
                 
Negative Swab 0/24 0%   0.0% 14.2% 0/24 0%   0% 14.2%
5% Positive Swab 2/24 8.3%   1.0% 27.0% 7/24 29.2%   12.6% 51.1%
95% Positive Swab 18/24 75%   53.3% 90.2% 24/24 100%   85.8% 100%
Moderate Positive Swab 24/24 100%   85.8% 100% 24/24 100%   86% 100%

 

 

The reproducibility of Rapid RSV test was evaluated at three clinical laboratory sites. The reproducibility panel was composed of 12 simulated RSV samples that were prepared in the same manner as for the precision study. The panel included moderate positive samples, low positive samples, high negative samples and negative samples. The panels were masked and randomized by BD prior to shipment to the clinical trial sites. Each site had two operators and each operator tested each panel for five consecutive days, resulting in a total of 60 samples tested per operator and 120 samples per site.

 

 

 

 

RSV Reproducibility (% RSV positive results)

 

 

Sample Site 1 Site 2 Site 3 Total
         
High 0% (0/30) 3.3% (1/30) 3.3% (1/30) 2.2% (2/90)
negative (95% CI: 0%, (95% CI: (95% CI: 0.6%,
(95% CI: 0.6%, 7.7%)
RSV 11.3%) 0.6%,16.7%) 16.7%)
 
Low positive 93.3% (28/30) 76.7% (23/30) 93.3% (28/30) 87.8% (79/90)
RSV (95% CI: 78.7%, (95% CI: 59.1%, (95% CI: 78.7%, (95% CI: 79.4%,
98.2%) 88.2%) 98.2%) 93%)
 
Moderate 100% (30/30) 100% (30/30) 100% (30/30) 100% (90/90)
positive (95% CI: 88.6%, (95% CI: 88.6%, (95% CI: 88.6%, (95% CI: 95.9%,
RSV 100%) 100%) 100%) 100%)
  0% (0/30) 0% (0/30) 0% (0/30) 0% (0/90)
Negative (95% CI: 0%, (95% CI: 0%, (95% CI: 0%,
(95% CI: 0%, 4.1%)
  11.3%) 11.3%) 11.3%)
   

 

 

 

 

 [#varpname#] 0

 

 

 

 
ORIENT NEW LIFE MEDICAL CO., LTD.
Contact: Jerry Meng
Email: Jerry @ newlifebiotest .com
Tel. +86 18657312116
SKYPE enetjerry
Get Latest Price For Your Requirement